Teva secures $33.75 billion financing commitment
Teva announced it has entered into commitment letters relating to its acquisition of Allergan’s generic pharmaceuticals business with Bank of America Merrill Lynch, Barclays Bank, BNP Paribas, Citi, Credit Suisse, HSBC, Mizuho Bank, Morgan Stanley, RBC Capital Markets and Sumitomo Mitsui Banking. July 31, 2015